Author
Listed:
- Fabien G. Lafaille
(Center for Stem Cell Biology, Sloan-Kettering Institute for Cancer Research
Developmental Biology Program, Sloan-Kettering Institute for Cancer Research)
- Itai M. Pessach
(Children's Hospital, Harvard Medical School
The Talpiot Medical Leadership Program, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 52621, Israel)
- Shen-Ying Zhang
(St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University
Laboratory of Human Genetics of Infectious Diseases, Institut National de la Santé et de la Recherche Médicale, University Paris Descartes, Necker Medical School, U980, Paris 75015, France)
- Michael J. Ciancanelli
(St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University)
- Melina Herman
(St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University
Laboratory of Human Genetics of Infectious Diseases, Institut National de la Santé et de la Recherche Médicale, University Paris Descartes, Necker Medical School, U980, Paris 75015, France)
- Avinash Abhyankar
(St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University)
- Shui-Wang Ying
(C.V. Starr Laboratory for Molecular Neuropharmacology, Weill Cornell Medical College)
- Sotirios Keros
(Weill Cornell Medical College)
- Peter A. Goldstein
(C.V. Starr Laboratory for Molecular Neuropharmacology, Weill Cornell Medical College)
- Gustavo Mostoslavsky
(Section of Gastroenterology, Boston University School of Medicine)
- Jose Ordovas-Montanes
(Children's Hospital, Harvard Medical School)
- Emmanuelle Jouanguy
(St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University
Laboratory of Human Genetics of Infectious Diseases, Institut National de la Santé et de la Recherche Médicale, University Paris Descartes, Necker Medical School, U980, Paris 75015, France)
- Sabine Plancoulaine
(Laboratory of Human Genetics of Infectious Diseases, Institut National de la Santé et de la Recherche Médicale, University Paris Descartes, Necker Medical School, U980, Paris 75015, France)
- Edmund Tu
(Center for Stem Cell Biology, Sloan-Kettering Institute for Cancer Research
Developmental Biology Program, Sloan-Kettering Institute for Cancer Research)
- Yechiel Elkabetz
(Laboratory for Pluripotent and Neural Stem Cell Biology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel)
- Saleh Al-Muhsen
(Prince Naif Center for Immunology Research, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia)
- Marc Tardieu
(Assistance Publique-Hôpitaux de Paris, Bicêtre Hospital, Kremlin-Bicêtre, 94275, France)
- Thorsten M. Schlaeger
(Children's Hospital and Dana-Farber Cancer Institute)
- George Q. Daley
(Children's Hospital and Dana-Farber Cancer Institute)
- Laurent Abel
(St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University
Laboratory of Human Genetics of Infectious Diseases, Institut National de la Santé et de la Recherche Médicale, University Paris Descartes, Necker Medical School, U980, Paris 75015, France)
- Jean-Laurent Casanova
(St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University
Laboratory of Human Genetics of Infectious Diseases, Institut National de la Santé et de la Recherche Médicale, University Paris Descartes, Necker Medical School, U980, Paris 75015, France
Pediatric Hematology-Immunology Unit, Necker Hospital)
- Lorenz Studer
(Center for Stem Cell Biology, Sloan-Kettering Institute for Cancer Research
Developmental Biology Program, Sloan-Kettering Institute for Cancer Research)
- Luigi D. Notarangelo
(Children's Hospital, Harvard Medical School
The Manton Center for Orphan Disease Research, Children’s Hospital)
Abstract
Neurons and oligodendrocytes differentiated from induced pluripotent stem cells (iPSCs) of patients with inherited TLR3 and UNC-93B deficiencies are found to be more susceptible to infection by HSV-1 than control cells because they fail to induce a normal interferon response, whereas neural stem cells and astrocytes are not susceptible.
Suggested Citation
Fabien G. Lafaille & Itai M. Pessach & Shen-Ying Zhang & Michael J. Ciancanelli & Melina Herman & Avinash Abhyankar & Shui-Wang Ying & Sotirios Keros & Peter A. Goldstein & Gustavo Mostoslavsky & Jose, 2012.
"Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells,"
Nature, Nature, vol. 491(7426), pages 769-773, November.
Handle:
RePEc:nat:nature:v:491:y:2012:i:7426:d:10.1038_nature11583
DOI: 10.1038/nature11583
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:491:y:2012:i:7426:d:10.1038_nature11583. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.